Article Details
Retrieved on: 2022-10-25 17:17:46
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca Plc. AZN+1.14%+ Free Alerts. has reported topline data from the MESSINA Phase 3 trial Fasenra (benralizumab) in Eosinophilic ...
Article found on: www.benzinga.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here